Paper Review Records
全部论文审稿周期
11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
25
天
EZH2 Inhibition Remodels Cell States and Enhances EGFRi Sensitization in Bladder Cancer
作者
Hongda Zhao; Jinyue Liao; Ho Vincy Wing Sze; Kang Liu; Xuan Chen; Hongwei Wu; Qiaoxiu Wang; Jiahui Hu; Peter Ho Yin Luk; Peter Ka-Fung Chiu; Chi Fai Ng; Dinglan Wu; Jeremy Yuen-Chun Teoh展开收起
作者单位
S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China; Department of Urology, Urology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Department of Urology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, China; Center for Translational Urological Research, Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China; Department of Urology, Medical University of Vienna, Vienna, Austria展开收起
84
天
Beyond Clear Cell: Rethinking Postoperative Surveillance for Non-clear Cell Renal Cell Carcinoma Subtypes
作者
Arighno Das; Elizabeth E. Ellis; Pheroze Tamboli; Priya Rao; Aradhana M. Venkatesan; Zhouxuan Li; Wei Qiao; Surena F. Matin; Jose A. Karam; Brittney H. Cotta展开收起
作者单位
Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA展开收起
7
天
Re: Michael Baboudjian, Alessandro Uleri, Julien Anract, et al. Targeted, Perilesional, and Distant Biopsies in Prostate Cancer. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.02.006
作者
Alexander Light; Hashim U. Ahmed; Taimur T. Shah展开收起
作者单位
Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK展开收起
150
天
DaBlaCa-13 Study: Five-year Follow-up from the Randomized Controlled Trial of Chemoresection with Intravesical Mitomycin C in Recurrent Ta Non-muscle-invasive Bladder Cancer
作者
Søren Klingenberg; Maria S. Lindgren; Jakob K. Jakobsen; Jørgen B. Jensen; Pernille S. Kingo展开收起
作者单位
Department of Urology, Aarhus University Hospital, Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus C, Denmark; Department of Urology, Aalborg University Hospital, Aalborg, Denmark展开收起
85
天
A Long Noncoding RNA-based Classifier for Identifying More Aggressive Low-grade Ta Bladder Cancer with Elevated FGFR3 Activity
作者
Tran Anh Thu Phung; Rachel Weng; Peter C. Black; Lars Dyrskjøt; Joep J. de Jong; Ewan A. Gibb展开收起
作者单位
Vancouver Prostate Centre, M. H. Mohseni Institute of Urologic Sciences, Vancouver, BC, Canada; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天